Product Information

METRONIDAZOLE 250 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1068 per EA under NDC 62135079590. Its NADAC has been published 124 times since Apr 10, 2024.

FDA first approved this application on Sep 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for METRONIDAZOLE 250 MG TABLET has been published 124 times since Apr 10, 2024, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.